Medical Science Liaison

Medical Science Liaison (MSL) – Oncology, France, Paris - Full-time - Hybrid

About Pharmanovia

Pharmanovia is a global speciality pharmaceutical company focused on innovative speciality medicines and trusted established brands. We partner with biotechnology innovators and pharmaceutical companies to bring important medicines to patients, while supporting established brands across more than 160 markets. Our model combines scientific, medical, regulatory, market access, supply chain and commercial expertise. We are building a targeted speciality portfolio in oncology, including oncology supportive care, as a major strategic development area, alongside selected opportunities in rare disease, neurology, and other speciality areas with a clear scientific rationale and unmet patient need.

About the Role

• Department: Medical Affairs – Scientific Affairs
• Location: France (Paris-based, field-based with national and European travel)
• Employment Type: Full-time

The Opportunity

We are seeking an experienced, scientifically credible Medical Science Liaison (MSL) to join our growing Medical Affairs team and deliver high-quality, non-promotional scientific engagement across France, with Paris as the primary territory. Reporting to the Global Head of Medical Affairs, with a dotted-line relationship to the General Manager, Southern Europe, you will translate the global Medical Affairs strategy into effective field execution, support national priorities, and ensure scientific readiness before, during, and after product launches. Your primary focus will be Oncology and oncology supportive care, including priority new chemical entities (NCEs), biologics and value-added medicine opportunities, with particular relevance to gynaecological oncology. You will build trusted peer-to-peer relationships with oncologists and other healthcare professionals, generate actionable medical insights, identify patient-pathway and evidence gaps, and support clinical and real-world evidence initiatives. This is a hands-on, externally focused position for an experienced MSL who can operate independently, exercise sound medical judgement, and collaborate across a growing international organisation. You will play an important role in shaping field Medical Affairs, supporting access readiness and ensuring that scientific and patient needs inform the company’s wider strategy.

Responsibilities

• Therapeutic Expertise: Maintain comprehensive, up-to-date knowledge of priority tumour types, oncology supportive care, patient pathways, biomarkers, diagnostics, standards of care, and the clinical evidence supporting Pharmanovia products and relevant comparators.
• Scientific Peer-to-Peer Engagement: Act as a credible scientific partner to external medical experts, communicating complex clinical data accurately, objectively and in a balanced, non-promotional manner.
• Clinical and Market Intelligence: Monitor developments in clinical practice, national and European guidelines, emerging evidence and healthcare service delivery to identify implications for patients, medical strategy and access readiness in France.
• External Stakeholder Relationships: Develop and maintain trusted professional relationships with priority oncologists, investigators, hospital pharmacists, specialist nurses, pathologists, palliative care specialists and other relevant healthcare professionals.
• Stakeholder Mapping and Planning: Develop and maintain a focused stakeholder engagement plan based on scientific relevance, patient needs, portfolio priorities and local healthcare requirements, rather than promotional targeting.
• Medical and Scientific Information: Conduct high-quality scientific discussions on disease areas, clinical evidence, treatment pathways and the appropriate use of Pharmanovia medicines, responding to unsolicited scientific enquiries through approved processes.
• National and Regional Expert Engagement: Establish relationships with relevant national and regional medical experts, scientific societies and cooperative groups to support the Medical Affairs strategy in France.
• Pre-Launch and Launch Readiness: Deliver assigned field Medical Affairs activities across pre-launch, launch and post-launch phases, ensuring alignment with agreed medical plans, priorities and milestones.
• Medical Readiness Activities: Support launch preparation through stakeholder mapping, scientific exchange, patient-pathway assessments, congress engagement, advisory boards, medical education and internal scientific readiness.
• Patient Pathway Assessment: Identify barriers affecting patient identification, diagnosis, biomarker testing, referral, treatment, supportive care and continuity of care, including home-care and palliative-care arrangements.
• Medical Execution and Problem Solving: Prioritise field activities according to the most important scientific and patient needs, taking ownership of practical execution challenges and escalating issues where broader support is required.
• Medical Insights and Intelligence: Capture, analyse and document high-quality insights from external scientific engagement, clearly distinguishing direct observations from interpretation.
• Strategic Insight Communication: Identify recurring themes, unmet medical needs, evidence gaps, access barriers, competitor developments, and changes in clinical practice, and communicate relevant findings to the Global Head of Medical Affairs, General Manager, Southern Europe, and wider global teams.
• Evidence Generation Opportunities: Identify opportunities for real-world evidence, registries, investigator-initiated research, Phase IV studies, post-authorisation studies and external scientific collaborations.
• Health Economics and Outcomes Evidence: Support identifying health-economic and outcomes evidence needs relevant to French healthcare settings, including hospital resource use, unplanned admissions, emergency visits, and regional differences in supportive, palliative, and home-care services.

Qualifications & Requirements

• Advanced scientific or clinical qualification in Medicine, Pharmacy, Biology, Biotechnology or an equivalent life-science discipline; a postgraduate specialisation, Master's degree or PhD is desirable.
• Typically, at least six years' successful experience as an MSL or in a comparable field Medical Affairs role within the pharmaceutical or biotechnology industry.
• Direct experience in Oncology, including field-based scientific engagement with oncology specialists and the ability to discuss complex clinical data confidently and credibly.
• Full professional fluency in French, with excellent written and spoken communication skills.
• Fluency in written and spoken English, with the ability to communicate scientific information effectively in an international business environment.
• Good understanding of the French oncology landscape and healthcare environment, including relevant patient pathways and access considerations.
• Proven ability to develop and maintain trusted peer-to-peer relationships with oncologists, KOLs, investigators and other relevant healthcare professionals.Strong scientific knowledge and the ability to interpret, critically assess and communicate complex clinical data and medical literature.
• Demonstrable experience developing stakeholder engagement plans and prioritising external scientific relationships.
• Experience generating, analysing, documenting and communicating actionable medical insights to inform medical strategy and business decisions.
• Experience supporting congresses, advisory boards, expert consultations, scientific meetings and medical education activities.
• Understanding of clinical development and evidence-generation activities, including clinical trials, investigator-initiated research, registries or post-authorisation studies.
• Knowledge of real-world evidence, health economics or outcomes research, or the ability to contribute effectively to related initiatives.
• Understanding of product launch preparation, pre-launch scientific readiness and post-launch Medical Affairs activities.
• Sound understanding of Medical Affairs governance, non-promotional scientific exchange and the importance of maintaining independent medical judgement.
• Knowledge of relevant French and European pharmaceutical legislation, industry codes, healthcare compliance and transparency requirements.
• Understanding of pharmacovigilance responsibilities, including the identification and timely reporting of adverse events and product complaints.
• Strong presentation, communication and interpersonal skills, with the ability to engage effectively with specialist healthcare professionals and internal stakeholders.
• Ability to work independently, manage a field-based territory, prioritise competing demands and take ownership of agreed objectives.
• Willingness and ability to travel regularly within France, with Paris as the primary territory, and attend national and European meetings as required.

Desirable Experience

• Medical qualification (MD) and/or postgraduate training directly relevant to Oncology.
• Recent experience in gynaecological oncology, ovarian cancer and/or malignant ascites.
• Experience with PARP inhibitors, biologics, antibodies, new chemical entities (NCEs), biomarkers or companion diagnostics.
• Experience supporting health-economic, outcomes or real-world evidence projects.
• Experience in pre-launch or launch environments where national reimbursement, regional access or hospital access was still being secured.
• Experience working within a lean speciality pharmaceutical or biotechnology organisation.
• Broader Medical Affairs experience across medical strategy, evidence generation, lifecycle management or cross-market projects.
• Experience using digital engagement platforms, medical insight analytics or AI-enabled Medical Affairs tools.
• Experience collaborating with Market Access, HEOR and Clinical Development teams.
• Experience contributing to national or European medical projects and cross-functional initiatives.

Pay range and compensation package

We offer a competitive salary plus a bonus and rewards package, including holidays, employee recognition awards, social events, a pension scheme, and hybrid working.

Equal Opportunity Statement

Pharmanovia is an equal-opportunity employer. Pharmanovia does not unlawfully discriminate against employees or applicants for employment based on an individual’s race, colour, religion, creed, sex, sexual orientation, gender identity or expression, national origin, genetic information, age, disability, marital status or any other status protected by applicable law. This policy applies to all terms, conditions, and privileges of employment, including recruitment, hiring, placement, compensation, promotion, discipline, and termination. Pharmanovia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.